Zeng Yi-Heng, Lin Bi-Wei, Su Hui-Zhen, Guo Xin-Xin, Li Yun-Lu, Lai Lu-Lu, Chen Wan-Jin, Zhao Miao, Yao Xiang-Ping
Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
Front Genet. 2021 Oct 18;12:732389. doi: 10.3389/fgene.2021.732389. eCollection 2021.
Primary familial brain calcification (PFBC) is a progressive neurological disorder manifesting as bilateral brain calcifications in CT scan with symptoms as parkinsonism, dystonia, ataxia, psychiatric symptoms, etc. Recently, pathogenic variants in have been linked to autosomal recessive PFBC. This study aims to elucidate the mutational and clinical spectrum of mutations in a large cohort of Chinese PFBC patients with possible autosomal recessive or absent family history. Mutational analyses of were performed by Sanger sequencing in a cohort of 245 PFBC patients including 21 subjects from 10 families compatible with a possibly autosomal-recessive trait and 224 apparently sporadic cases. In-depth phenotyping and neuroimaging features were investigated in all patients with novel variants. Two nonsense variants (c.442C > T, p. Q148*; c.972C > A, p. Y324*) and two missense variants (c.1969G>C, p. G657R; c.2033C > G, p. P678R) of were identified in four sporadic PFBC patients, respectively. These four novel variants were absent in gnomAD, and their amino acid were highly conserved, suggesting these variants have a pathogenic impact. Patients with variants tend to display a homogeneous clinical spectrum, showing extensive brain calcification and parkinsonism, dysarthria, ataxia, or vertigo. Our findings supported the pathogenic role of variants in PFBC and identified two pathogenic variants (c.442C > T, c.972C > A), one likely pathogenic variant (c.2033C > G), and one variant of uncertain significance (c.1969G>C), further expanding the genetic and phenotypic spectrum of PFBC-.
原发性家族性脑钙化(PFBC)是一种进行性神经疾病,在CT扫描中表现为双侧脑钙化,症状包括帕金森症、肌张力障碍、共济失调、精神症状等。最近,[基因名称]的致病变异已与常染色体隐性PFBC相关联。本研究旨在阐明一大群可能具有常染色体隐性遗传或无家族病史的中国PFBC患者中[基因名称]突变的突变谱和临床谱。对245例PFBC患者进行了桑格测序以分析[基因名称]的突变,其中包括来自10个家族的21名符合可能的常染色体隐性特征的受试者以及224例明显散发的病例。对所有具有新型[基因名称]变异的患者进行了深入的表型分析和神经影像学特征研究。在4例散发的PFBC患者中分别鉴定出[基因名称]的两个无义变异(c.442C>T,p.Q148*;c.972C>A,p.Y324*)和两个错义变异(c.1969G>C,p.G657R;c.2033C>G,p.P678R)。这四个新型变异在gnomAD中不存在,并且它们的氨基酸高度保守,表明这些变异具有致病影响。具有[基因名称]变异的患者倾向于表现出相似的临床谱,表现为广泛的脑钙化和帕金森症、构音障碍、共济失调或眩晕。我们的研究结果支持了[基因名称]变异在PFBC中的致病作用,并鉴定出两个致病变异(c.442C>T,c.972C>A)、一个可能致病的变异(c.2033C>G)和一个意义未明的变异(c.1969G>C),进一步扩展了PFBC-[基因名称]的遗传和表型谱。